Multiple sclerosis (MS) is
Introduction
Multiple sclerosis (MS) is an autoimmune disease characterized by perivascular inflammation and localized myelin destruction in the central nervous system. 1 Symptoms are usually perceived in young adulthood, and women outnumber men by nearly 2:1. 2 In 80% of patients the disease manifests itself by relapses followed by remissions (RRMS). After a period of about 10 years, in 50% of cases the course becomes secondarily progressive (SPMS). ෂ10% of MS patients exhibit a primary progressive (PPMS) course of the disease. 3 A plausible hypothesis for disease manifestation concerns the effect of still unknown environmental factors in genetically susceptible individuals. Concordance rates of 26% in monozygotic twins compared with 2.3% in dizygotic twins emphasize the relevance of the genetic contribution. 4 The presumed pathophysiology of MS is based on deranged autoimmune responses in genetically susceptible individuals. Putative autoantigens like myelin basic protein or myelin-oligodendrocyte protein are presented by MHC class II molecules on antigen presenting cells. T lymphocytes recognize the presented antigen via the T-cell receptor.
An inflammatory immune response commences, mediated by T and B cells as well as macrophages, and it leads to destruction of myelin sheaths.
Different strategies are pursued to elucidate the genetic background of MS. Whole genome scans did not reveal concordant results for candidate regions with the exception of the human leukocyte antigen complex (HLA) region on chromosome 6. HLA class II genes contribute to predisposition, for example the genotype HLA-DRB1* 15 implies a nearly four-fold relative risk (RR) to develop MS. 5 On the other hand, the candidate gene approach comprises the search for mutations, polymorphisms and sequence variations (MPSV) in a large number of genes relevant in the pathogenesis of the disease, eg in the regulation of the immune system. Therefore, we searched for MPSV in genes of the nuclear factor kappa B (NFB) cascade in order to investigate an association with MS. NFB is an ubiquitous transcription factor of particular importance in inflammatory and immune responses. Activated NFB is a heterodimer composed usually of the p65 and p50 subunits. Other constituents include rel, relB, v-rel or p52. The different forms of NFB activate different target genes. 6 Each member of the subunits exhibits a conserved N-terminal region, the Rel-homology domain (RHD) containing the DNA-binding and dimerization domains and the nuclear localization signal (NLS). 7 In unstimulated cells NFB heterodimers are bound to inhibitory proteins (IBs) masking the NLS in order to prevent translocation from the cytoplasm into the nucleus. 6 These IB proteins belong to a functionally related family comprising IB␣, IB␤, IB␥, IB⑀, BCL3, p100, p105, IKBL. 8 A common feature of these molecules is the ankyrin repeat of 30-33 amino acids. The specific interaction between NFB and IB is mediated through binding between the ankyrin repeat and the RHD. 7 When cells are stimulated by cytokines or viruses, IB is phosphorylated by specific kinases causing its rapid degradation. The release of IB from NFB results in the transfer of the latter into the nucleus to induce gene expression necessary for the (auto-)immune reaction.
Results
NFKB1 is localized on chromosome 4q23-q24 and is composed of 24 exons.
9 NFKB3 comprises 10 exons and is located on chromosome 11q22-q13. 10 Part of exons 1 and 2 of NFKB1 as well as the promotor and exon 1 of NFKB3 failed to amplify by PCR despite of various primer combinations and many different conditions tested (see also Wintermeyer et al 11 ). Single-strand conformation polymorphism (SSCP) analyses of the 10 exons of NFKB3 encoding the p65 subunit of NFB did not reveal any band shifts, thus virtually excluding variation. SSCP analysis of the 24 exons of the NFKB1 gene encoding the p50 subunit revealed band shifts in exons 12 and 17, which were visible under both gel conditions used in this study. Direct sequencing unmasked a C to T transition in exon 12 that does not result in an amino acid exchange (A380A). The allele and genotype frequencies of this polymorphism are similar among MS patients and controls. In exon 17 we found a rare amino acid exchange from leucine to phenylalanine (L614F). The frequency is too low for use in association studies.
Because of the low variability of the coding sequence of the NFKB1 gene, a highly polymorphic (CA) n microsatellite mapping to the NFKB1 locus was analysed in our cohorts of MS patients and controls. 12 The allelic distribution in the patient group corresponds to the control group. Also, in the groups of patients with different courses of MS no predisposing alleles were evident ( Figure 1 ).
BCL3 is a potential inhibitor of NFB. The BCL3 gene is located on chromosome 19q13 and is composed of 9 exons. 13 A microsatellite in intron 2 of BCL3 revealed no MS association (Figure 2 ).
14 SSCP band shifts were apparent in exons 6, 7, 8 and 9. Thus in ෂ1.7 kb of BCL3 sequence four variations were identified by sequencing. Three rare silent exchanges were confirmed in exons 6 and 7 (Table 1 ). In exon 8 a change from proline to alanine (P287A) was found in only one of 172 MS patients and none of 92 controls. In the 3Ј-untranslated region a variable (C) n stretch was evident. MS associations were excluded.
The IKBL gene is located in the HLA region on chromosome 6p21.3, a consistently verified region influencing MS predisposition. The protein shows structural similarities to those of the IB family. Three single nucleotide polymorphisms of the IKBL gene (accession ID X77909) -two in the promotor sequence, one in exon 4 -have been typed here. The 738C allele in exon 4 was overrepresented in the group of MS patients (13.1% vs 7.5%; P Ͻ 0.001), especially in the group of patients with a relapsing/remitting course of MS (RRMS 14.9%; P Ͻ 0.0001). This T/C exchange leads to an amino acid substitution (C224R). The allele frequencies are shown in Table  1 . This represents the first description of a predisposing allele for the RRMS patient group. This exchange is probably of functional relevance, since cysteine is a highly reactive and structurally relevant amino acid.
IB␣ represents another inhibitor of NFB. The corresponding gene (NFKBIA) is located on chromosome 14q13 and contains six exons spanning 3.5 kb. 15 Many sequence variations were identified in this gene, but none of them results in changes of the amino acid sequence. The typing results for five base exchanges in the promotor as well as two silent exchanges in the coding sequence, two intronic exchanges and an exchange in the 3Ј-untranslated region are shown in Table 1 . The newly identified allele of the promotor occurred with lower frequency in the group of PPMS (eg −708ins8 15.4% vs 28.4% in the control group; P Ͻ 0.01).
Interestingly, results from combinatorial evaluations demonstrate strong effects (Tables 2 and 3 ): Given predisposing alleles increase MS risk dramatically in certain combinations (combinations of alleles with BCL3 N217N allele 02 or IKBL C224R allele 02, respectively). This fact is evident for both models considered, additive or single count.
Protecting effects were less evident (but see BCL3 N217N allele 01, IKBL C224R allele 01). RRMS patients can be differentiated from the total group of MS: IKBL C224R allele 02 appears to exert stronger effects than BCL3 N217N allele 02 in RRMS vs the entire MS group (see Table 1 ). This effect is particularly obvious in the combinatorial analysis according to the single count 
Discussion
MS may be regarded as a multifactorial autoimmune disease. A still unknown number of alleles from different loci appears to influence MS susceptibility and especially combinations of distinct alleles appear to contribute to the risk. 5 Thus, the candidate gene approach is a powerful method to evaluate MS associations by analysing a great number of polymorphic sites. 16, 17 The NFB cascade comprises candidates for MS susceptibility because of the involvement of its members in virtually all immunological reactions. An elegant method to detect MPSV is SSCP analysis. 18 Using two different gel conditions for polymerase chain reaction (PCR) fragments shorter than 200 bp is sufficient to achieve a detection sensitivity of almost 100% for MPSV. 19 In this study genes of NFB subunits as well as inhibitors were included. Regarding their genomic size, a striking observation was the low MPSV rate in the NFKB1 and NFKB3 genes. Although every 200-500th nucleotide is expected to vary in man on average, 16, 17 in altogether ෂ7 kb NFKB gene sequence only two exchanges were identified, a silent base exchange in exon 12 (A380A) and a rare variant in exon 17 (L614F) of NFKB1. No sequence variation whatsoever was found in NFKB3. Theoretically this failure could be due to limited sensitivity of the SSCP method. Yet, our extensive SSCP experiences make this highly improbable. 19 Therefore, we suppose that the highly conserved amino acid sequence is based on the important function of NFB underlying the central role of this transcription factor in a great number of signaling pathways. The constancy at the nucleotide level is even more intriguing, because in addition to the possibilities of third position variability in the protein-encoding exons, introns and other non-translated regions were partly covered. We have to conclude that unknown mechanisms on the nucleotide level preserve these genomic regions from mutating and/or the fixation of DNA variability in evolution. Comparing the human mRNA of NFKB1 to other species underscores the high level of conservation, eg the homology between humans and macaques is 92%, between humans, mouse and rat 87%.
The genes of the NFB inhibitors show more variability in their sequence. However, most of the MPSV are silent 20 They play an important role in protecting cells from any kind of stress including heat, ischemia, inflammation. Expression studies have to reveal the exact functional meaning.
A major conclusion from these analyses includes that distinct combinations of alleles in the inhibitory part of the NFB cascade strongly influence disease susceptibility. Major effects of single alleles (BCL3 N217N allele 02, IKBL C224R allele 02) are modified by further alleles epistatically. Such effects can only be revealed by combined analyses of multiple loci. Naturally, combinations are more infrequent than single alleles. However, also in single allele analyses, often rare alleles contribute more significantly (as is the case here with BCL3 N217N allele 02) than common alleles. This fact agrees with the assumption of a complex disease which includes genetic heterogeneity. In this study, only a single combination remains significant after a stringent Bonferroni correction for the single count model (see Tables 3 and 4 ). As for other association studies our findings are not proved even after scholarly statistical analysis because of the explorative nature of association studies. However, they add to the complex puzzle of genetic analysis in MS. HLA-DRB1*15 stratification did not show remarkable differences. In terms of statistical significance only one allele (IKBL C224R, 02) stood up. Since IKBL is linked to the HLA region, this finding integrates with other associations at 6p21.3, which are difficult to assess for their individual contributions on account of linkage disequilibrium. This result is in accordance with the assumption that the NFB cascade integrates with many immunological pathways and can therefore effectively modulate immune response in MS patients with heterogeneous risk factors. Our results indicate that heterogeneity may be present even within a single signalling pathway alongside with various interactions. In a more general view of complex diseases this outcome suggests that not only many pathways have to be investigated but also each of them meticulously.
Materials and methods

Patients and controls
Peripheral blood samples as well as informed consent from more than 400 healthy blood donors were provided by the department of transplantation and immunology of the University Hospital Eppendorf (Hamburg, Germany). The mean age of the healthy donors was 39.3 ± 11.47 years. The male/female rate was 1.4 ± 0.5. More than 800 unrelated MS patients attended by the Department of Neurology, University clinics of Bochum and Gö ttingen (Germany) participated in this study. The male/female rate was 1.7 ± 0.47, the mean age at MS onset was 29.9 ± 9.63 years. A total of 55.3% of all clinically characterized MS patients exhibited RRMS, 25.8% developed SPMS and 18.9% were characterized by PPMS. The mean expanded disability status scale (EDSS) of all MS patients was 4.2 ± 2.31, of PPMS 5.8 ± 1.91 and of RRMS+SPMS 3.9 ± 2.25. Table 5 . PCR cycling started with initial denaturation for 5 min at 94°C. The annealing temperature of the first cycle was 6°C, of the second cycle 3°C higher than the remaining 26 cycles to achieve high specificity at the beginning of the reaction and to increase the quantity of PCR products in the following cycles. The annealing time was 1 min. Extension was performed at 72°C for 1 min with final extension of 5 min. Restriction enzyme digestion of PCR products Ͼ200 bp was performed according to the manufacturer's recommendations. PCR products were electrophoresed by loading restricted fragments onto vertical denaturing or non-denaturing 6% polyacrylamide (PAA) gels. The native PAA gels used for SSCP analysis were carried out at 4°C. Each PCR system was tested under two different gel conditions. Five percent glycerine was added to the first gel, 2.5% glycerine and 1 M urea to the second. Results were documented by autoradiography. Direct sequencing of PCR products was performed on a 373A sequencing automate using the BigDye Terminator Cycle Sequencing Kit (PE Applied Biosystems).
SSCP and microsatellite analyses
Statistical analysis
Comparisons of the frequencies of single alleles and allele combinations were performed by Fisher's exact test in a Genes and Immunity 2×2 contingency table. P c values are corrected for the number of all alleles/allele combinations tested using a Bonferroni correction. In the correction factor we excluded those alleles/allele combinations which occurred less frequently than 20 times altogether, since we did not include these loci/alleles/allele combinations in the final assessment. The respective correction factors are mentioned in a footnote to each table for which P values are reported. In order to account for the multifactorial nature of MS, 21 we have investigated the effect of allele combinations (ACs) on disease predisposition. Different alleles at several loci may interact epistatically. 22 As for single loci several models exist to account for effects of homozygosity if the full genotype is not considered. 23 Additive effects give equal weight to each allele present, thereby increasing the impact of homozygous individuals as compared to heterozygous individ-uals. A model (called also phenotypic model for single loci) evaluates homozygous and heterozygous individuals in an identical manner, which we call the 'single count' model here, since for each individual any allele combination is counted at most once for each individual (in contrast to the additive model).
We have scrutinized the association data, both, under additive and single count models. Note that ACs derived from one individual are not independent (eg an individual which is heterozygous at two biallelic loci carries ACs: 1/1, 1/2, 2/1, 2/2, but we can derive ACs 1/2, 2/1 from ACs 1/1, 2/2 and vice versa). Nevertheless, we have computed P values for listed ACs which are to give a measure of evidence for the risk contributed. More exact P values can be obtained by statistical simulation (Bö hringer S, dissertation submitted to the Faculty of Medicine, RUB, Bochum, Germany). We base our interpretation of P values on the single count model, for which P value are exact. For each table listing ACs we show, both, a nominal P value and a P value corrected for the number of tests performed. Nominal P values are reported to allow for proper interpretation and account for the explorative nature of association studies. [24] [25] [26] 
